VascuBio Innovation
PrivateLast Round
Accelerator
Mar 12, 2026
Total Funding Raised
$299,431
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VascuBio Innovation operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was an Accelerator round in March 2026.
VascuBio Innovation is a life sciences company that develops advanced 3D bioprinting, bioreactor, and microfluidic platforms for tissue engineering and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, 3D Printing, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VascuBio Innovation Comparables
Compare VascuBio Innovation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VoxCell BioInnovation | 90% | |
| FluidForm Bio | 85% | |
| TissUse | 84% |
For institutional investors. Book with your work email.
VascuBio Innovation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 12, 2026 | ||||
| Grant | Nov 20, 2025 | ||||
| Grant | Mar 31, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VascuBio Innovation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consortium Québécois sur la découverte du médicament | Grant |
| Gouvernement du Québec | Grant |
| Ontario Genomics | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 12, 2026
$150K raised from Federal Economic Development Agency and Ontario Genomics.
- Nov 20, 2025
Received funding from Consortium Québécois, Gouvernement du Québec, and Pfizer Canada.
For institutional investors. Book with your work email.
VascuBio Innovation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VascuBio Innovation's valuation, stock price, and market status.
Is VascuBio Innovation a public or private company?
VascuBio Innovation is a private company.
What is the current stock price of VascuBio Innovation?
VascuBio Innovation is a private company, so its shares have no public market price. Caplight tracks VascuBio Innovation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VascuBio Innovation worth (valuation)?
Valuation information for VascuBio Innovation is not publicly available.
Can I buy VascuBio Innovation stock?
VascuBio Innovation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VascuBio Innovation's last funding round?
VascuBio Innovation's most recent funding round was Accelerator on March 12, 2026.
Who are the main investors in VascuBio Innovation?
Key investors in VascuBio Innovation include Consortium Québécois sur la découverte du médicament, Gouvernement du Québec, Ontario Genomics.
Will VascuBio Innovation IPO soon?
No public IPO plans have been announced for VascuBio Innovation.
How can I track VascuBio Innovation secondary market activity?
Caplight tracks bids, offers, and trades in VascuBio Innovation's shares on secondary markets.